OK Biotech Co., Ltd. (TPE:4155)
Taiwan · Delayed Price · Currency is TWD 16.15
-0.15 (-0.92%)
Jul 18, 2025, 1:35 PM CST
OK Biotech Revenue
OK Biotech had revenue of 412.37M TWD in the quarter ending March 31, 2025, with 17.06% growth. This brings the company's revenue in the last twelve months to 1.73B, up 41.44% year-over-year. In the year 2024, OK Biotech had annual revenue of 1.67B with 40.11% growth.
Revenue (ttm)
1.73B
Revenue Growth
+41.44%
P/S Ratio
1.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.67B | 478.05M | 40.11% |
| Dec 31, 2023 | 1.19B | -291.54M | -19.65% |
| Dec 31, 2022 | 1.48B | 220.15M | 17.43% |
| Dec 31, 2021 | 1.26B | -221.04M | -14.89% |
| Dec 31, 2020 | 1.48B | 243.16M | 19.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |